Cálculo del riesgo aterogénico en pacientes con enfermedad renal crónica. Una valoración complementaria en el riesgo cardiovascular

Fürstenheim Milerud, Laura Paloma; Amat Camats, Gemma; Vilela Pájaro, Álvaro; García Serrano, Cristina.
Metas enferm ; 23(7): 16-23, sept. 2020. graf, tab
Artículo en Español | IBECS (España) | ID: ibc-196458

Documentos relacionados

  1. [Correlation between dyslipidemia and rheumatoid arthritis associated interstitial lung disease].
  2. Dyslipidemia in Pediatric Patients: A Cross-Sectional Study.
  3. Control of residual dyslipidaemic risk.
  4. THE SIGNIFICANCE OF CIRCULATING SURFACTANT PROTEIN D AND DYSLIPIDEMIA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE, CORONARY HEART DISEASE AND THEIR COMBINATION.
  5. Short-Term Effect of Nutraceutical Fruit Juices on Lipid Metabolism in Patients with Acquired Hypercholesterolemia.
  6. Unmasking the morphological alteration of erythrocytes among women suffering from PCOS.
  7. The association of the steatosis severity, NAFLD fibrosis score and FIB-4 index with atherogenic dyslipidaemia in adult patients with NAFLD: A cross-sectional study.
  8. Immune Mechanisms in Inflammatory Anemia.
  9. Cardiometabolic factors and risk of non-arteritic anterior ischemic optic neuropathy: a systematic review and meta-analysis.
  10. Obesity and Dyslipidemia.